{"id":1460,"date":"2025-08-30T10:35:24","date_gmt":"2025-08-30T07:05:24","guid":{"rendered":"https:\/\/dppcco.com\/?p=1460"},"modified":"2025-09-03T12:40:40","modified_gmt":"2025-09-03T09:10:40","slug":"%d8%a7%d9%81%d8%aa%d8%aa%d8%a7%d8%ad-%d8%af%d9%88-%d8%ae%d8%b7-%d8%aa%d9%88%d9%84%db%8c%d8%af-%d9%85%d8%a7%d8%af%d9%87-%d9%85%d8%a4%d8%ab%d8%b1%d9%87-%d8%af%d8%a7%d8%b1%d9%88%db%8c%db%8c-%d8%af%d8%b1","status":"publish","type":"post","link":"https:\/\/dppcco.com\/en\/2025\/08\/30\/%d8%a7%d9%81%d8%aa%d8%aa%d8%a7%d8%ad-%d8%af%d9%88-%d8%ae%d8%b7-%d8%aa%d9%88%d9%84%db%8c%d8%af-%d9%85%d8%a7%d8%af%d9%87-%d9%85%d8%a4%d8%ab%d8%b1%d9%87-%d8%af%d8%a7%d8%b1%d9%88%db%8c%db%8c-%d8%af%d8%b1\/","title":{"rendered":"Opening of two active pharmaceutical ingredient production lines in Kermanshah on the occasion of Government Week"},"content":{"rendered":"<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><\/blockquote>\n\n\n\n\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><\/blockquote>\n\n\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><\/blockquote>\n\n\n\n\n\n<ul class=\"wp-block-list\">\n\n\n\n\n\n\n\n<\/ul>\n\n\n\n\n\n\n\n\n\n\n\n<p class=\"wp-block-paragraph\">Inauguration of Two Active Pharmaceutical Ingredient (API) Production Lines in Kermanshah<br>In a formal ceremony, two new API production lines were inaugurated at the DPPCCO plant in Kermanshah, with the presence of senior national officials.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This industrial project marks a significant milestone in strengthening the country\u2019s pharmaceutical infrastructure and expanding production capacity in western Iran. It is considered a pivotal step toward pharmaceutical self-sufficiency and enhancing export capabilities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Minister of Cooperatives and CEO of Shasta Attend the Opening Ceremony<br>The event was attended by Dr. Ahmad Meydari, Minister of Cooperatives, Labour, and Social Welfare; Dr. Mohammadreza Saeedi, CEO of the Social Security Investment Company (Shasta); Dr. Manouchehr Habibi, Governor of Kermanshah; members of parliament representing Kermanshah; and deputy governors. The officials toured various sections of the facility.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The two production lines were constructed across three floors, covering a total area of 1,100 square meters, including 500 square meters of cleanroom space. The facility is equipped with eight reactors and three centrifuges. The estimated annual production capacity exceeds 100 tons of API, which will play a vital role in meeting domestic demand and reducing reliance on imports.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DPPCCO New API Lines: A Symbol of National Capability<br>During the ceremony, the Minister emphasized the importance of developing the pharmaceutical industry, stating:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cThe inauguration of these production lines is a symbol of national capability in the health and knowledge-based production sectors, and it can contribute to sustainable employment in the region.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A Strategic Step Toward Regional Market Presence<br>The CEO of Shasta highlighted the strategic role of the project in the pharmaceutical supply chain, noting:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cExpanding API production capacity in western Iran is part of our broader strategy to establish a strong presence in regional and global markets.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Governor of Kermanshah also expressed appreciation for the efforts made, adding:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cThis industrial project not only contributes to the province\u2019s economic development but also elevates Kermanshah\u2019s standing in the national pharmaceutical industry.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Strategic Products to Be Manufactured<br>The new production lines are expected to manufacture key and strategic pharmaceutical compounds, including:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pregabalin (for neuropathic pain and anxiety)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Fenofibrate (lipid-lowering agent)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acyclovir (antiviral)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Lamotrigine (anticonvulsant and mood stabilizer)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Famotidine (acid reducer)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DPPCCO Strategic Role in Iran\u2019s Pharmaceutical Industry<br>As a subsidiary of Tamin Pharmaceutical Company and Shasta, Inauguration of Two Active Pharmaceutical Ingredient (API) Production Lines in Kermanshah<br>In a formal ceremony, two new API production lines were inaugurated at the DPPCCO plant in Kermanshah, with the presence of senior national officials.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This industrial project marks a significant milestone in strengthening the country\u2019s pharmaceutical infrastructure and expanding production capacity in western Iran. It is considered a pivotal step toward pharmaceutical self-sufficiency and enhancing export capabilities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Minister of Cooperatives and CEO of Shasta Attend the Opening Ceremony<br>The event was attended by Dr. Ahmad Meydari, Minister of Cooperatives, Labour, and Social Welfare; Dr. Mohammadreza Saeedi, CEO of the Social Security Investment Company (Shasta); Dr. Manouchehr Habibi, Governor of Kermanshah; members of parliament representing Kermanshah; and deputy governors. The officials toured various sections of the facility.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The two production lines were constructed across three floors, covering a total area of 1,100 square meters, including 500 square meters of cleanroom space. The facility is equipped with eight reactors and three centrifuges. The estimated annual production capacity exceeds 100 tons of API, which will play a vital role in meeting domestic demand and reducing reliance on imports.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DPPCCO API Lines: A Symbol of National Capability<br>During the ceremony, the Minister emphasized the importance of developing the pharmaceutical industry, stating:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cThe inauguration of these production lines is a symbol of national capability in the health and knowledge-based production sectors, and it can contribute to sustainable employment in the region.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A Strategic Step Toward Regional Market Presence<br>The CEO of Shasta highlighted the strategic role of the project in the pharmaceutical supply chain, noting:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cExpanding API production capacity in western Iran is part of our broader strategy to establish a strong presence in regional and global markets.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Governor of Kermanshah also expressed appreciation for the efforts made, adding:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cThis industrial project not only contributes to the province\u2019s economic development but also elevates Kermanshah\u2019s standing in the national pharmaceutical industry.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Strategic Products to Be Manufactured<br>The new production lines are expected to manufacture key and strategic pharmaceutical compounds, including:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pregabalin (for neuropathic pain and anxiety)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Fenofibrate (lipid-lowering agent)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acyclovir (antiviral)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Lamotrigine (anticonvulsant and mood stabilizer)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Famotidine (acid reducer)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DPPCCO Strategic Role in Iran\u2019s Pharmaceutical Industry<br>As a subsidiary of Tamin Pharmaceutical Company and Shasta, Daroupakhsh Chemidarou has long played a pivotal role in API production. Leveraging cutting-edge technical expertise, advanced infrastructure, and skilled personnel, the company has made significant contributions to supplying essential pharmaceutical raw materials nationwide.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With the launch of the new lines in Kermanshah, DPPCCO has not only expanded its production capacity but also taken a major step toward industrial decentralization and balanced regional development. Today, the company is recognized as a key player in the national pharmaceutical supply chain, contributing to reduced import dependency, improved quality of domestically produced medicines, and expanded exports.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Looking ahead, DPPCCO aims to solidify its position as a national brand in Iran\u2019s pharmaceutical industry by focusing on knowledge-based production, diversifying its product portfolio, and entering regional and international markets. has long played a pivotal role in API production. Leveraging cutting-edge technical expertise, advanced infrastructure, and skilled personnel, the company has made significant contributions to supplying essential pharmaceutical raw materials nationwide.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With the launch of the new lines in Kermanshah, DPPCCO has not only expanded its production capacity but also taken a major step toward industrial decentralization and balanced regional development. Today, the company is recognized as a key player in the national pharmaceutical supply chain, contributing to reduced import dependency, improved quality of domestically produced medicines, and expanded exports.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Looking ahead, DPPCCO aims to solidify its position as a national brand in Iran\u2019s pharmaceutical industry by focusing on knowledge-based production, diversifying its product portfolio, and entering regional and international markets.<\/p>","protected":false},"excerpt":{"rendered":"<p>\u0627\u0641\u062a\u062a\u0627\u062d \u062f\u0648 \u062e\u0637 \u062a\u0648\u0644\u06cc\u062f \u0645\u0627\u062f\u0647 \u0645\u0624\u062b\u0631\u0647 \u062f\u0627\u0631\u0648\u06cc\u06cc \u062f\u0631 \u0634\u06cc\u0645\u06cc \u062f\u0627\u0631\u0648\u06cc\u06cc \u062f\u0627\u0631\u0648\u067e\u062e\u0634 \u06a9\u0631\u0645\u0627\u0646\u0634\u0627\u0647  <\/p>","protected":false},"author":3,"featured_media":1461,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[31],"class_list":["post-1460","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-news","tag-31"],"_links":{"self":[{"href":"https:\/\/dppcco.com\/en\/wp-json\/wp\/v2\/posts\/1460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dppcco.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dppcco.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dppcco.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/dppcco.com\/en\/wp-json\/wp\/v2\/comments?post=1460"}],"version-history":[{"count":7,"href":"https:\/\/dppcco.com\/en\/wp-json\/wp\/v2\/posts\/1460\/revisions"}],"predecessor-version":[{"id":1476,"href":"https:\/\/dppcco.com\/en\/wp-json\/wp\/v2\/posts\/1460\/revisions\/1476"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dppcco.com\/en\/wp-json\/wp\/v2\/media\/1461"}],"wp:attachment":[{"href":"https:\/\/dppcco.com\/en\/wp-json\/wp\/v2\/media?parent=1460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dppcco.com\/en\/wp-json\/wp\/v2\/categories?post=1460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dppcco.com\/en\/wp-json\/wp\/v2\/tags?post=1460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}